Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.250
-0.040 (-3.10%)
Jan 28, 2026, 12:52 PM EST - Market open
Celularity Market Cap
Celularity has a market cap or net worth of $36.05 million as of January 28, 2026. Its market cap has decreased by -26.12% in one year.
Market Cap
36.05M
Enterprise Value
103.84M
1-Year Change
-26.12%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $36.05M, a decrease of -89.76%. That is a compound annual growth rate of -29.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 36.62M | 15.86% |
| Dec 31, 2025 | 31.61M | -32.41% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Passage Bio | 39.57M |
| Generation Bio Co. | 38.33M |
| Atara Biotherapeutics | 38.14M |
| Lantern Pharma | 37.58M |
| OnKure Therapeutics | 37.39M |
| Cingulate | 36.21M |
| Lisata Therapeutics | 35.90M |
| RenovoRx | 35.86M |